LifeBridge Innovations, PBC — SEC Form D Filing

LifeBridge Innovations, PBC filed an SEC Form D on July 13, 2026, reporting $3.38M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
July 13, 2026
Amount reported
$3.38M
Round stage
Seed
Industry
Medical Devices
Website
https://lifebridgeinnovations.com/

What the company does

Securities: Simple Agreements for Future Equity (SAFEs). Exemption: Rule 506(c). Incorporated: DELAWARE

Problem

Existing cancer treatments often fail, especially in advanced stages where the disease is recurrent and resistant, and current Tumor Treating Fields (TTF) systems are limited to treating tumors in a single location, making them ineffective for diffuse or widespread metastatic cancer.

Solution

LifeBridge Innovations is developing the LB10000 device, an Adaptive Tumor Treating Fields (ATTF) platform that uses patented programmable disc technology to dynamically target multiple areas of the body simultaneously, offering new hope for Stage IV patients with widespread metastatic disease.

Verdict

This cleared because the technology promised a substantial expansion of a validated treatment modality, allowing investors to quantify the market delta if successful, not because the company had established clinical proof points. Investors were implicitly betting on a breakthrough in a historically challenging domain, where current options are limited and patient need is acute. This limited upside by anchoring the financial model to an incremental improvement of an existing solution, rather than opening an entirely new market category.

Source: SEC EDGAR Form D filing